Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

AstraZeneca’s Lynparza meets primary endpoint in cancer trial

Lynparza is being developed to treat a variety of cancers. Credit: © AstraZeneca.



  • AstraZeneca’s Lynparza meets primary endpoint in pancreatic cancer trial

Go Top